CLINICAL_TRIALS
trial_result
· 2015-11-20
Clinical Trial Update: Treatment of Dysphagia in Oculopharyngeal Muscular Dystrophy by Autologous Transplantation of Myoblasts [Phase 2]
Summary
A completed Phase 2 trial investigating autologous myoblast transplantation to treat dysphagia in patients with oculopharyngeal muscular dystrophy.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Muscular Dystrophy, Oculopharyngeal | Phase 2 | Status: COMPLETED